Ignite Creation Date:
2024-05-06 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05246280
Status:
TERMINATED
Last Update Posted:
2024-06-10
First Post:
2021-12-16
Brief Title:
Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA
Sponsor:
Navidea Biopharmaceuticals
Organization:
Navidea Biopharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-16
First Submit QC Date:
February 8 2022
Study First Post Date:
2022-02-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-23
Last Update Post Date:
2024-06-10
Last Update Post Date Type:
ACTUAL